Applications of Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate in Industrial Manufacturing

As a direct manufacturer specializing in advanced piperidine derivatives, we supply Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate to strict industrial and pharmaceutical standards for use in high-value downstream applications. The following scenarios outline major sectors that incorporate this intermediate, detailing regulatory standards, technical usage ratios, integration points, and final product categories.

1. Chiral Pharmaceutical Intermediate for Antiviral Drug Synthesis

Our raw material functions as a key enantiopure building block in the synthesis of several next-generation antiviral active pharmaceutical ingredients (APIs), where its stereospecificity is critical for bioactivity. It is precisely dosed in multi-step asymmetric syntheses under validated procedures, directly impacting the final enantiomeric purity of the API.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• EU GMP Part II
• Chinese Pharmacopoeia (ChP) monographs for antiviral APIs
• FDA 21 CFR Part 211 for finished pharmaceuticals

Typical usage ratio

• 15–22 mol% in the initial chiral center installation step; adjusted through in-process chiral HPLC to achieve required optical purity, batch-to-batch basis

Downstream process integration

• Enters as a starting material for the first-stage amide coupling or reductive amination
• Undergoes protection/deprotection sequences and catalytic asymmetric reactions
• Participates in successive purification (crystallization, flash chromatography) for use in the API core structure

Final product types

• Oseltamivir phosphate (antiviral tablets, suspensions)
• Advanced intermediates for orally available flu therapeutics
• Research quantities of prodrugs for clinical candidate evaluation

2. Intermediate for CNS-Active Pyridine Derivative Drug Compounds

Our material serves as a controlled precursor for the synthesis of highly regulated central nervous system (CNS) active compounds, where piperidine moieties must maintain precise stereochemistry throughout the production chain. Downstream users rely on its consistent chiral purity to avoid isomer formation associated with reduced pharmacological safety in final products.

Industry compliance standards

• USP–NF: United States Pharmacopeia & National Formulary monographs
• EU REACH substance registration for pharmaceutical intermediates
• ISO 9001:2015 certified batch traceability
• Local Controlled Substances regulations (China NMPA, US DEA precursor management)

Typical usage ratio

• 10–18% of total batch input mass; actual level determined by the chiral transfer step requirements and target impurity profile

Downstream process integration

• Deployed during the convergent synthesis of piperidine-substituted pyridine rings
• Feeds directly into N-alkylation or Grignard functionalization steps
• Monitored for enantiomeric excess using GC or 2D-NMR through all intermediates

Final product types

• Nootropic actives in clinical trial formulations
• CNS-stimulant pharmaceutical grade fine chemicals
• Reference standards for pharmacology research

3. Starting Material in Custom Synthesis for Chiral Ligand Manufacturing

The compound operates as a foundational substrate for chiral ligand producers supplying to organometallic and transition metal catalyst developers. In these downstream labs, the raw material’s enantioselectivity underpins the fidelity of ligand formation, which ultimately determines the stereochemical outcome in catalytic pharmaceutical and agrochemical reactions.

Industry compliance standards

• ISO 9001:2015 for specialty chemical manufacturing
• OECD Good Laboratory Practice (GLP) for catalyst R&D batches
• Hazardous Chemical Safety Management Regulation (China MOH 591)
• REACH compliance for European custom syntheses

Typical usage ratio

• 0.5–1.1 equivalent per chiral ligand synthesis; fine-tuned based on the target ligand’s backbone requirements and conversion rates in pilot batches

Downstream process integration

• Initial step in ligand construction via direct amidation or esterification
• Features in stereoretentive reduction protocols
• Purified by preparative chromatography as part of ligand QC workflows

Final product types

• Chiral ligands for asymmetric hydrogenation in API synthesis
• Enantioselective catalysts marketed to pharma and agrochemical producers
• Screening libraries for high-throughput catalyst development

4. Protected Intermediate for Peptide Fragment Synthesis

In the peptide and oligoamide segment, contract manufacturing organizations (CMOs) employ this material as a protected amino component during solid-phase or solution-phase fragment coupling. Its stable ester group and defined stereochemistry enable high-yield fragment assembly prior to final deprotection, yielding advanced peptide therapeutics and custom peptide derivatives.

Industry compliance standards

• EMA Guidelines on process validation for finished products (human and veterinary)
• cGMP (current Good Manufacturing Practices) for peptide API manufacturing
• USP peptide and peptidomimetic monographs
• Japanese Pharmacopoeia (JP) for regulatory submissions

Typical usage ratio

• 3–7 mol% relative to core fragment mass, adjusted depending on the number of protected piperidine sites and desired sequence length in each production run

Downstream process integration

• Included in protected fragment during automated peptide synthesizer loading
• Participates in stepwise coupling and N-terminal capping reactions
• Deprotected and isolated after cyclization and side-chain removal stages

Final product types

• Peptide-based APIs for metabolic and CNS indications
• Custom peptidomimetics for biotech research clients
• Quality control standards for method validation in peptide analysis

5. Stereoselective Intermediate for Agrochemical Synthesis

Downstream agrochemical active ingredient manufacturers utilize our material as a stereo-defined intermediate in the construction of complex piperidine scaffolds, especially for new-generation insecticidal and fungicidal compounds. Its consistent chiral profile helps maintain registration-required isomer specificity throughout multi-step process lines.

Industry compliance standards

• FAO/WHO Specifications for plant protection products
• ISO 17025 testing and calibration traceability
• Chinese National Standards for technical grade agrochemicals
• OECD Guidelines for the Testing of Chemicals (for toxicity and residue levels)

Typical usage ratio

• 2–5% on total technical concentrate mass; tailored per synthetic route efficiency and required enantiomeric excess after final formulation

Downstream process integration

• Charged in mid-stage ring-closure or heteroatom functionalization reactions
• Integration monitored via chromatographic purity and optical rotation analyses
• Blended into bulk technical powder or concentrated solution for downstream granulation

Final product types

• Piperidine-substituted insecticidal actives
• Fungicidal technical concentrates for crop protection formulators
• Analytical standards for regulatory residue analysis